Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02980341 |
|---|---|
| Brief Title: | Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer |
| First Submitted : | November 28, 2016 |
| First Submitted that Met QC Criteria : | November 30, 2016 |
| First Posted : | December 2, 2016 (Estimate) |
| Certification/Extension First Submitted : | July 18, 2022 |
| Certification/Extension First Submitted that Met QC Criteria : | July 27, 2022 |
| Certification/Extension First Posted : | July 29, 2022 |
| Last Update Submitted that Met QC Criteria : | December 13, 2023 |
| Last Update Posted : | December 15, 2023 |